PubMed=1573271; DOI=10.4049/jimmunol.148.9.2834
Steele J.K., Domingo R., Gomi H., Ishizaka K.
Serologic, biologic and western blot analysis of human IgE-binding factor derived from a T cell hybridoma maintained in protein-free medium.
J. Immunol. 148:2834-2839(1992)

PubMed=1730869; DOI=10.4049/jimmunol.148.3.729
Thomas P., Gomi H., Takeuchi T., Carini C., Tagaya Y., Ishizaka K.
Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient.
J. Immunol. 148:729-737(1992)

Patent=WO1994026923A1
Ishizaka K., Liu Y.-C., Mikayama T.
Method for recombinant production of biologically active polypeptides.
Patent number WO1994026923A1, 24-Nov-1994

PubMed=7511819; DOI=10.1073/pnas.91.7.2824; PMCID=PMC43463
Gomi H., Tagaya Y., Nakano T., Mikayama T., Ishizaka K.
Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.
Proc. Natl. Acad. Sci. U.S.A. 91:2824-2828(1994)

Patent=US5565338
Ishizaka K.
Suppressor T-cell hybridoma and production of allergen specific glycosylation inhibiting factor.
Patent number US5565338, 15-Oct-1996

Patent=US5723582
Ishizaka K.
Antigen-specific human glycosylation inhibiting factor.
Patent number US5723582, 03-Mar-1998